These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 2423611)

  • 1. Analysis of a cytostatic lymphokine produced by incubation of lymphocytes with tumor cells: relationship to leukoregulin and distinction from recombinant lymphotoxin, recombinant tumor necrosis factor, and natural killer cytotoxic factor.
    Sayers TJ; Ransom JH; Denn AC; Herberman RB; Ortaldo JR
    J Immunol; 1986 Jul; 137(1):385-90. PubMed ID: 2423611
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of cytostatic/cytotoxic lymphokines: relationship of natural killer cytotoxic factor to recombinant lymphotoxin, recombinant tumor necrosis factor, and leukoregulin.
    Ortaldo JR; Ransom JR; Sayers TJ; Herberman RB
    J Immunol; 1986 Nov; 137(9):2857-63. PubMed ID: 3093586
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Studies on the mechanism of natural killer cell-mediated cytotoxicity. VII. functional comparison of human natural killer cytotoxic factors with recombinant lymphotoxin and tumor necrosis factor.
    Wright SC; Bonavida B
    J Immunol; 1987 Mar; 138(6):1791-8. PubMed ID: 3493288
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Natural killer-sensitive targets stimulate production of TNF-alpha but not TNF-beta (lymphotoxin) by highly purified human peripheral blood large granular lymphocytes.
    Peters PM; Ortaldo JR; Shalaby MR; Svedersky LP; Nedwin GE; Bringman TS; Hass PE; Aggarwal BB; Herberman RB; Goeddel DV
    J Immunol; 1986 Oct; 137(8):2592-8. PubMed ID: 3760569
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Distinction of partially purified human natural killer cytotoxic factor from recombinant human tumor necrosis factor and recombinant human lymphotoxin.
    Bialas T; Kolitz J; Levi E; Polivka A; Oez S; Miller G; Welte K
    Cancer Res; 1988 Feb; 48(4):891-8. PubMed ID: 3257413
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of rat natural killer cytotoxic factor (NKCF) produced by rat NK cell lines and the production of a murine monoclonal antibody that neutralizes NKCF.
    Ortaldo JR; Winkler-Pickett R; Morgan AC; Woodhouse C; Kantor R; Reynolds CW
    J Immunol; 1987 Nov; 139(9):3159-65. PubMed ID: 3668253
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Leukoregulin, a direct-acting anticancer immunological hormone that is distinct from lymphotoxin and interferon.
    Ransom JH; Evans CH; McCabe RP; Pomato N; Heinbaugh JA; Chin M; Hanna MG
    Cancer Res; 1985 Feb; 45(2):851-62. PubMed ID: 3881174
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumor targets stimulate IL-2 activated killer cells to produce interferon-gamma and tumor necrosis factor.
    Chong AS; Scuderi P; Grimes WJ; Hersh EM
    J Immunol; 1989 Mar; 142(6):2133-9. PubMed ID: 2493506
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Studies on the mechanism of natural killer cell-mediated cytotoxicity. IV. Interferon-induced inhibition of NK target cell susceptibility to lysis is due to a defect in their ability to stimulate release of natural killer cytotoxic factors (NKCF).
    Wright SC; Bonavida B
    J Immunol; 1983 Jun; 130(6):2965-8. PubMed ID: 6189909
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Studies on the mechanism of natural killer cytotoxicity. III. Activation of NK cells by interferon augments the lytic activity of released natural killer cytotoxic factors (NKCF).
    Wright SC; Bonavida B
    J Immunol; 1983 Jun; 130(6):2960-4. PubMed ID: 6189908
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human interleukin 1 is a cytocidal factor for several tumor cell lines.
    Onozaki K; Matsushima K; Aggarwal BB; Oppenheim JJ
    J Immunol; 1985 Dec; 135(6):3962-8. PubMed ID: 2415593
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IFN-gamma treatment of K562 cells inhibits natural killer cell triggering and decreases the susceptibility to lysis by cytoplasmic granules from large granular lymphocytes.
    Grönberg A; Ferm MT; Ng J; Reynolds CW; Ortaldo JR
    J Immunol; 1988 Jun; 140(12):4397-402. PubMed ID: 3131433
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Natural killer (NK) cell-derived hematopoietic colony-inhibiting activity and NK cytotoxic factor. Relationship with tumor necrosis factor and synergism with immune interferon.
    Degliantoni G; Murphy M; Kobayashi M; Francis MK; Perussia B; Trinchieri G
    J Exp Med; 1985 Nov; 162(5):1512-30. PubMed ID: 3932579
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of interleukin 2, interferon-gamma, and mitogens on the production of tumor necrosis factors alpha and beta.
    Nedwin GE; Svedersky LP; Bringman TS; Palladino MA; Goeddel DV
    J Immunol; 1985 Oct; 135(4):2492-7. PubMed ID: 3928750
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytotoxic lymphokines produced by cloned human cytotoxic T lymphocytes. II. A novel CTL-produced cytotoxin that is antigenically distinct from tumor necrosis factor and alpha-lymphotoxin.
    Green LM; Reade JL; Ware CF; Devlin PE; Liang CM; Devlin JJ
    J Immunol; 1986 Dec; 137(11):3488-93. PubMed ID: 2431035
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of NK cell cytotoxic factor against fresh human tumors.
    Uchida A; Fukata H
    Nat Immun; 1993; 12(4-5):267-78. PubMed ID: 8257831
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Initial characterization of a lymphokine pathway for the immunologic induction of tumor necrosis factor-alpha release from human peripheral blood mononuclear cells.
    Kornbluth RS; Gregory SA; Edgington TS
    J Immunol; 1988 Sep; 141(6):2006-15. PubMed ID: 3139748
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Studies on the mechanism of natural killer cytotoxicity. II. coculture of human PBL with NK-sensitive or resistant cell lines stimulates release of natural killer cytotoxic factors (NKCF) selectively cytotoxic to NK-sensitive target cells.
    Wright SC; Weitzen ML; Kahle R; Granger GA; Bonavida B
    J Immunol; 1983 May; 130(5):2479-83. PubMed ID: 6833762
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Membrane-associated lymphotoxin-expressing lymphokine-activated killer cells up-regulate intercellular adhesion molecule-1 expression on target tumor cells in vitro.
    Kimura K; Abe Y; Horiuchi A; Miyake M; Kimura S
    Cell Immunol; 1995 Aug; 164(1):119-25. PubMed ID: 7634343
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human peripheral blood lymphocytes targeted with bispecific antibodies release cytokines that are essential for inhibiting tumor growth.
    Qian JH; Titus JA; Andrew SM; Mezzanzanica D; Garrido MA; Wunderlich JR; Segal DM
    J Immunol; 1991 May; 146(9):3250-6. PubMed ID: 1826709
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.